Patients receiving the tafasitamab combination achieved a median PFS of 22.4 months, compared with 13.9 months for patients receiving placebo with lenalidomide and rituximab. This represents a 57% ...

Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and are effective disease-modifying treatments for several autoimmune diseases. Whether baricitinib preserves β-cell ...

Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg/m2 or greater - ...

How can we tell if a depression treatment works beyond placebo? A new real-world method measuring placebo shows that ...

Evidence from a clinical trial and long-term cohort studies suggests metformin, widely used in diabetes, may reduce knee ...

Andrew Nixon, spokesman for Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., announced on Thursday that moving forward, “all new vaccines will undergo safety testing in ...

Este artículo estará disponible en español en El Tiempo Latino. Health and Human Services Secretary Robert F. Kennedy Jr. has a long history of undermining confidence in vaccine safety, including by ...